Page last updated: 2024-10-25

clofibric acid and Broad Beta Disease

clofibric acid has been researched along with Broad Beta Disease in 3 studies

Clofibric Acid: An antilipemic agent that is the biologically active metabolite of CLOFIBRATE.
clofibric acid : A monocarboxylic acid that is isobutyric acid substituted at position 2 by a p-chlorophenoxy group. It is a metabolite of the drug clofibrate.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaffarnik, H1
Schneider, J1
Schubotz, R1
Zöfel, P1
Hausmann, L1
Goebel, KM1
Naruszewicz, M1
Nowicka, G1
Szostak, WB1
Kłosiewicz-Latoszek, L1
Richard, P1
de Zulueta, MP1
Beucler, I1
De Gennes, JL1
Cassaigne, A1
Iron, A1

Other Studies

3 other studies available for clofibric acid and Broad Beta Disease

ArticleYear
Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
    Artery, 1980, Volume: 8, Issue:6

    Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Creatine Kinase; Female; gamma-Glutamyltransfe

1980
[Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Kardiologia polska, 1982, Volume: 25, Issue:7-8

    Topics: Adult; Aged; Apolipoproteins; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans;

1982
Identification of a new apolipoprotein E variant (E2 Arg142-->Leu) in type III hyperlipidemia.
    Atherosclerosis, 1995, Jan-06, Volume: 112, Issue:1

    Topics: Aged; Amino Acid Sequence; Apolipoproteins E; Clofibric Acid; Fibric Acids; Genotype; Humans; Hyperl

1995